Bioventus Inc. is a medical device company. The Companyâs portfolio of products is grouped into three areas. Its Pain Treatments include the Knee Osteoarthritis (KOA) area, and Peripheral Nerve Stimulation (PNS) area. Its Surgical Solutions include Ultrasonics, which offers precision bone resection for patients with degenerative spine conditions and spinal deformities, and Bone Graft Substitutes (BGS), which includes a range of products that facilitate optimal bone fusion following a surgical procedure. Its Restorative Therapies comprise Fracture Care that provide low-intensity pulse ultrasound to help patients who suffer from bone fractures that do not heal through traditional methods. It offers a diverse portfolio of products to support physicians in relieving pain and addressing musculoskeletal challenges across indications and clinical areas, including knee, hand and upper extremities, foot and ankle, podiatry, trauma, general surgery, spine and neurosurgery.
äŒæ¥ã³ãŒãBVS
äŒç€ŸåBioventus Inc
äžå Žæ¥Feb 11, 2021
æé«çµå¶è²¬ä»»è
ãCEOãClaypoole (Robert E)
åŸæ¥å¡æ°930
蚌åžçš®é¡Ordinary Share
æ±ºç®ææ«Feb 11
æ¬ç€Ÿæåšå°4721 Emperor Boulevard, Suite 100
éœåžDURHAM
蚌åžååŒæNASDAQ OMX - NASDAQ BASIC
åœUnited States of America
éµäŸ¿çªå·27703
é»è©±çªå·19194746700
ãŠã§ããµã€ãhttps://www.bioventus.com/
äŒæ¥ã³ãŒãBVS
äžå Žæ¥Feb 11, 2021
æé«çµå¶è²¬ä»»è
ãCEOãClaypoole (Robert E)